Comparative Effectiveness of Telemonitoring Versus Usual Care for Heart Failure: A Systematic Review and Meta-analysis

Authors Yun JE , Park JE , Park HY , Lee HY , Park DA - More
Category Systematic review
Journal Journal of cardiac failure
Year 2018
Background This study aimed to evaluate the effectiveness of telemonitoring (TM) in the management of patients with heart failure (HF). Methods and Results We searched Ovid-Medline, Ovid-Embase, and the Cochrane Library for randomized controlled trials published through May 2016. Outcomes of interest included clinical effectiveness (mortality, hospitalization, and emergency department visits) and patient-reported outcomes. TM was defined as the transmission of individual biologic data, such as weight, blood pressure, and heart rate. Thirty-seven randomized controlled trials (9582 patients) of TM met the inclusion criteria: 24 studies on all-cause mortality, 17 studies on all-cause hospitalization, 12 studies on HF-related hospitalization, and 5 studies on HF-related mortality. The risks of all-cause mortality (risk ratio [RR] 0.81, 95% confidence interval [CI] 0.70–0.94) and HF-related mortality (RR 0.68, 95% CI 0.50–0.91) were significantly lower in the TM group than in the usual care group. TM showed a significant benefit when ≥3 biologic data are transmitted or when transmission occurred daily. TM also reduced mortality risk in studies that monitored patients’ symptoms, medication adherence, or prescription changes. Conclusions TM intervention reduces the mortality risk in patients with HF, and intensive monitoring with more frequent transmissions of patient data increases its effectiveness. © 2017 Elsevier Inc.
Epistemonikos ID: e3e238e5865e174c1fa964cfa657dbea8809024a
First added on: Sep 26, 2017
VersionVersion informationActions
Latest
Current 		{{version.n}}{{ ordinal_suffix(version.n) }}
Current 		Oldest
Current

{{version.title}}

EpisteDB date
{{version.db_date}}
Publication date
{{version.pub_date}}
{{ext_id.source}}
{{ext_id.id}}